2nd Quarter - Report — NATIONAL PATIENT ADVOCATE FOUNDATION for NATIONAL PATIENT ADVOCATE FOUNDATION (2008)

Firm

NATIONAL PATIENT ADVOCATE FOUNDATION

Client

NATIONAL PATIENT ADVOCATE FOUNDATION

Income

—

Expenses

$55,881

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Labor HHS Appropriations: appropriations levels for NIH, NCI, CDC and AHRQ Agriculture Appropriations: appropriations level for FDA

Lobbyist	Covered position, as disclosed
EMILY BROWN	—
NANCY DAVENPORT-ENNIS	—
JIM GOTTLIEB	—
AMY WOTRING	—

Contacted: Natl Institutes of Health (NIH); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Medicare/Medicaid MMM

Medicare reimbursement, social security disability,

Lobbyist	Covered position, as disclosed
EMILY BROWN	—
NANCY DAVENPORT-ENNIS	—
JIM GOTTLIEB	—
AMY WOTRING	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

patient safety and quality improvement, positron emission tomography (PET), hospital inpatient prospective payment system

Lobbyist	Covered position, as disclosed
EMILY BROWN	—
NANCY DAVENPORT-ENNIS	—
JIM GOTTLIEB	—
AMY WOTRING	—

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE; Natl Institutes of Health (NIH)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.